Type 2 Diabetes

The Type 2 Diabetes pipeline: 145 tracked drugs, 38 approved for this indication.

38 approved / phase 466 Phase 325 Phase 29 Phase 12 US approval withdrawn5 preclinical / unstaged

Compare the share prices of listed companies in Type 2 Diabetes →

Total attributable cost

$324.6B

$12,022/patient

Drug spend

$126.1B

$4,670/patient

How this is calculated ↗

All severities · US

The Type 2 Diabetes pipeline

Key trial results for every approved and late-stage drug: Type 2 Diabetes results by drug.

← all assets